Utility of Animal Models for Evaluating Preclinically Novel HBV Therapeutics

Time: 2:30 pm
day: Day One

Details:

• Why doesn’t HBV infect mice and how can the barrier be overcome?

• Analyze advances in development of (immunocompetent) humanized mice

• Discuss emerging NHP models for modeling chronic HBV

Speakers: